IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways
Wang, Xiaomeng, Xu, Jiali, Chen, Jin, Jin, Shidai, Yao, Jiaqi, Yu, Tongfu, Wang, Wei, Guo, RenhuaVolume:
9
Language:
english
Journal:
Frontiers in Oncology
DOI:
10.3389/fonc.2019.01167
Date:
November, 2019
File:
PDF, 1.42 MB
english, 2019